anti-glypican 3/CD3 bispecific antibody ERY974

{
  "id": "MLC-T-ONC-010708",
  "term": "anti-glypican 3/CD3 bispecific antibody ERY974",
  "field": "Oncology and biomedicine",
  "definition": "An anti-glypican 3 (GPC3; GPC-3)/anti-CD3 bispecific monoclonal antibody, with potential immunostimulating and antineoplastic activities. Anti-GPC3/CD3 bispecific antibody ERY974 possesses two antigen-recognition and binding sites, one for the CD3 complex, a group of T-cell surface glycoproteins that complex with the T-cell receptor (TCR), and one for GPC3, a tumor-associated antigen (TAA) overexpressed on the surface of certain tumor cells. Upon administration of ERY974, this bispecific antibody simultaneously binds to both CD3-expressing and GPC3-expressing cells, thereby crosslinking GPC3-expressing tumor cells and cytotoxic T lymphocytes (CTLs). This may result in potent CTL-mediated lysis of GPC3-expressing tumor cells. GPC3, a heparan sulfate proteoglycan and an oncofetal antigen protein, is overexpressed in a variety of cancers; it plays a role in cell division and growth regulation.",
  "synonyms": [
    "anti-GPC3/CD3 BiAb ERY974",
    "anti-GPC3/CD3 bispecific antibody ERY974"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-glypican-3-cd3-bispecific-antibody-ery974/"
}